Inhibition of 5alpha-reductase enhances testosterone-induced expression of U19/Eaf2 tumor suppressor during the regrowth of LNCaP xenograft tumor in nude mice.
Efficacy and safety of dutasteride on prostate cancer risk reduction in Asian men: the results from the REDUCE study.
Glutathione S-transferase (GST) gene variants and risk of benign prostatic hyperplasia: a report in a North Indian population.
(51/97)Glutathione S-transferases may be over expressed in benign prostate hyperplasia (BPH) but association of GST polymorphism with susceptibility to the disease is unclear. The objective of this study was to determine relationships between polymorphisms in the GSTM1, T1 and P1 genes with risk of symptomatic BPH and response to standard therapy. The study population comprised 160 symptomatic BPH patients with BPE (benign prostatic enlargement) and LUTS (lower urinary tract symptoms) and 200 age-matched controls. Patient inclusion criteria were: age>50 years; prostate size>30 cm3; AUA (American Urological Association) score>7; and PVR volume+info)
A potential biochemical mechanism underlying the influence of sterol deprivation stress on Caenorhabditis elegans longevity.
Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial.
Battling prostate cancer with 5-alpha-reductase inhibitors: a pyrrhic victory?
Inhibition of the M. tuberculosis 3beta-hydroxysteroid dehydrogenase by azasteroids.
Biopsy misidentification identified by DNA profiling in a large multicenter trial.